Cargando…
Design and evaluation of EphrinA1 mutants with cerebral protective effect
The activation of EphA2 receptor by its natural ligand EphrinA1 causes blood brain barrier dysfunction, and inactivation of EphA2 reduces BBB damage in ischemic stroke. Thus, EphA2 targeted antagonists may serve as neuroprotective agents. We engineered four mutants of EphrinA1, EM1, EM2, EM3 and EM4...
Autores principales: | Zhu, Yuanjun, Gao, Yuanqing, Zheng, Danping, Shui, Mengyang, Yu, Kuai, liu, Xiaoyan, Lin, Yuan, Su, Li, Yang, Wenxing, Wang, Yinye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432519/ https://www.ncbi.nlm.nih.gov/pubmed/28507312 http://dx.doi.org/10.1038/s41598-017-02091-7 |
Ejemplares similares
-
Modeling Development in Retinal Afferents: Retinotopy, Segregation, and EphrinA/EphA Mutants
por: Godfrey, Keith B., et al.
Publicado: (2014) -
Role of EphrinA3 in HIV-1 Neuropathogenesis
por: Singal, Chitra Mohinder Singh, et al.
Publicado: (2021) -
EphrinA5 protein distribution in the developing mouse brain
por: Deschamps, Claire, et al.
Publicado: (2010) -
EphrinA1-Fc attenuates myocardial ischemia/reperfusion injury in mice
por: DuSablon, Augustin, et al.
Publicado: (2017) -
Binding of EphrinA5 to RET receptor tyrosine kinase: An in vitro study
por: Liu, Yixin, et al.
Publicado: (2018)